Blood & Marrow Stem Cell Transplantation: Clinical Trials & Research

Here you can find descriptions of key transplantation clinical trials offered at Memorial Sloan-Kettering. For eligibility and contact information, select a study from the list below.

You can also learn more about Memorial Sloan-Kettering’s accomplishments in improving blood and marrow stem cell transplantation.

Showing 4 trials
Titlesort icon Investigator
A Non-Myeloablative Conditioning Regimen with Peri-Transplant Rituximab and Stem Cell Transplantation in Patients with B-cell Non-Hodgkin's Lymphoma
[Protocol 06-150] 		Castro-Malaspina, Hugo, MD
A Reduced Intensity Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with Acute Leukemia or Myelodysplasia
[Protocol 08-087] 		Barker, Juliet, MBBS
A Study of Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post-Transplantation Donor Lymphocyte Infusions for Patients with Relapsed or High-Risk Multiple Myeloma
[Protocol 10-051] 		Koehne, Guenther, MD, PhD
A Trial of Single Autologous Transplant with or without Consolidation Therapy versus Tandem Autologous Transplant with Lenalidomide Maintenance for Patients with Multiple Myeloma
[Protocol 09-171] 		Landau, Heather, MD
Recommended Links